These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32154530)

  • 1. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer.
    Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R
    J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy.
    Cheng X; Zeng X; Zheng Y; Fang Q; Wang X; Wang J; Tang R
    J Colloid Interface Sci; 2020 Apr; 565():254-269. PubMed ID: 31978788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy.
    Ni R; Zhu J; Xu Z; Chen Y
    J Mater Chem B; 2020 Feb; 8(6):1290-1301. PubMed ID: 31967176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer.
    Cheng X; Li D; Sun M; He L; Zheng Y; Wang X; Tang R
    Colloids Surf B Biointerfaces; 2019 Sep; 181():185-197. PubMed ID: 31132609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
    Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
    Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
    Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J
    Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor.
    Xu J; Yan X; Ge X; Zhang M; Dang X; Yang Y; Xu F; Luo Y; Li G
    J Mater Chem B; 2021 Feb; 9(5):1297-1314. PubMed ID: 33443252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Y
    Wang Y; Jiang Z; Yuan B; Tian Y; Xiang L; Li Y; Yang Y; Li J; Wu A
    Biomater Sci; 2019 Nov; 7(11):4748-4757. PubMed ID: 31508613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluronic micelles with suppressing doxorubicin efflux and detoxification for efficiently reversing breast cancer resistance.
    Cheng X; Lv X; Xu J; Zheng Y; Wang X; Tang R
    Eur J Pharm Sci; 2020 Apr; 146():105275. PubMed ID: 32087259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma.
    Zhang L; Lu J; Qiu L
    Int J Nanomedicine; 2016; 11():5205-5220. PubMed ID: 27785023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
    Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOX-loaded peptide dendritic copolymer nanoparticles for combating multidrug resistance by regulating the lysosomal pathway of apoptosis in breast cancer cells.
    Wang J; Li N; Cao L; Gao C; Zhang Y; Shuai Q; Xie J; Luo K; Yang J; Gu Z
    J Mater Chem B; 2020 Feb; 8(6):1157-1170. PubMed ID: 31951231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
    Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
    Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin-grafted and pH-sensitive dextran micelles for overcoming inflammation-mediated multidrug resistance in breast cancer.
    Zeng X; Cheng X; Zheng Y; Yan G; Wang X; Wang J; Tang R
    Carbohydr Polym; 2020 Jun; 237():116139. PubMed ID: 32241443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer.
    Cao A; Ma P; Yang T; Lan Y; Yu S; Liu L; Sun Y; Liu Y
    Mol Pharm; 2019 Jun; 16(6):2502-2510. PubMed ID: 30998372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
    Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
    [No Abstract]   [Full Text] [Related]  

  • 18. Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy.
    Hu C; Zhuang W; Yu T; Chen L; Liang Z; Li G; Wang Y
    J Mater Chem B; 2020 Jun; 8(24):5267-5279. PubMed ID: 32441291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity.
    Zhang B; Wan S; Peng X; Zhao M; Li S; Pu Y; He B
    J Mater Chem B; 2020 May; 8(17):3939-3948. PubMed ID: 32236239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.